| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |